Bulletin
Investor Alert

NeuroBo Pharmaceuticals Inc.

NAS: NRBO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 31, 2023, 7:59 p.m.

/zigman2/quotes/207284462/composite

$

0.80

Change

+0.0050 +0.63%

Volume

Volume 24,148

Quotes are delayed by 20 min

/zigman2/quotes/207284462/composite

Today's close

$ 0.81

$ 0.79

Change

-0.02 -2.45%

Day low

Day high

$0.77

$0.81

Open

52 week low

52 week high

$0.55

$63.85

Open

Insider Actions for NeuroBo Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/24/2019 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
100,000   Award at $0 per share. 0
07/24/2019 Steven R. Gullans
President & CEO; Director
300,000   Award at $0 per share. 0
07/24/2019 Andrew H. Sassine
Director
15,000   Award at $0 per share. 0
07/24/2019 Seth Reno
Chief Commercial Officer
100,000   Award at $0 per share. 0
07/24/2019 Pedro Lichtinger
Director
15,000   Award at $0 per share. 0
07/24/2019 Kenneth W Kousky
Director
15,000   Award at $0 per share. 0
02/08/2018 Steven R. Gullans
President & CEO; Director
71,429   Acquisition at $7 per share. 500,003
02/08/2018 Seth Reno
Chief Commercial Officer
14,286   Acquisition at $7 per share. 100,002
08/14/2017 Jeffrey S. Mathiesen
Chief Financial Officer
3,207   Derivative/Non-derivative trans. at $3.59 per share. 11,513
08/10/2017 Jeffrey S. Mathiesen
Chief Financial Officer
3,000   Derivative/Non-derivative trans. at $3.59 per share. 10,770
08/10/2017 Jeffrey S. Mathiesen
Chief Financial Officer
3,000   Derivative/Non-derivative trans. at $3.59 per share. 10,770
07/31/2017 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
4,474   Derivative/Non-derivative trans. at $1.34 per share. 5,995
03/10/2017 Steven R. Gullans
President & CEO; Director
52,798   Acquisition at $9.47 per share. 499,997
03/10/2017 Andrew H. Sassine
Director
21,119   Acquisition at $9.47 per share. 199,996
03/10/2017 P. Kent Hawryluk
Director
25,000   Acquisition at $9.47 per share. 236,750
03/10/2017 Pedro Lichtinger
Director
10,559   Acquisition at $9.47 per share. 99,993
02/01/2017 Kenneth W Kousky
Director
110,428   0
02/01/2017 Kenneth W Kousky
Director
101,406   0
08/10/2016 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
51,750   Acquisition at $10 per share. 517,500
08/10/2016 Steven R. Gullans
President & CEO; Director
500,000   Acquisition at $10 per share. 5,000,000
08/10/2016 David Lowenschuss
Chief Legal Off. & Secretary
11,120   Acquisition at $10 per share. 111,200
08/10/2016 Mina Patel Sooch
President & CEO; Director
52,500   Acquisition at $10 per share. 525,000
08/10/2016 Seth Reno
Chief Commercial Officer
4,000   Acquisition at $10 per share. 40,000
08/10/2016 P. Kent Hawryluk
Director
25,000   Acquisition at $10 per share. 250,000
08/10/2016 Pedro Lichtinger
Director
10,000   Acquisition at $10 per share. 100,000
08/10/2016 Kenneth W Kousky
Director
1,000   Acquisition at $10 per share. 10,000
08/10/2016 Jeffrey S. Mathiesen
Chief Financial Officer
4,000   Acquisition at $10 per share. 40,000
08/10/2016 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
19,228   Derivative/Non-derivative trans. at $6.71 per share. 129,019
08/10/2016 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
16,144   Derivative/Non-derivative trans. at $6.71 per share. 108,326
08/10/2016 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
59,561   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 Steven R. Gullans
President & CEO; Director
306,025   Derivative/Non-derivative trans. at $6.71 per share. 2,053,427
08/10/2016 Mina Patel Sooch
President & CEO; Director
27,141   Derivative/Non-derivative trans. at $6.71 per share. 182,116
08/10/2016 Mina Patel Sooch
President & CEO; Director
11,078   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 Daniela Carmen Oniciu
Vice President
2,237   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 Andrew H. Sassine
Director
31,853   Derivative/Non-derivative trans. at $6.71 per share. 213,733
08/10/2016 Andrew H. Sassine
Director
75,080   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 P. Kent Hawryluk
Director
23,616   Derivative/Non-derivative trans. at $6.71 per share. 158,463
08/10/2016 P. Kent Hawryluk
Director
7,457   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 Pedro Lichtinger
Director
39,274   Derivative/Non-derivative trans. at $6.71 per share. 263,528
08/10/2016 Kenneth W Kousky
Director
116,891   Derivative/Non-derivative trans. at $6.71 per share. 784,338
08/10/2016 Kenneth W Kousky
Director
95,439   Derivative/Non-derivative trans. at $0 per share. 0
08/10/2016 Jeffrey S. Mathiesen
Chief Financial Officer
3,927   Derivative/Non-derivative trans. at $6.71 per share. 26,350
08/10/2016 Charles L. Bisgaier
Chief Scientific Off. & Chair; Director
6,515   43,715
08/10/2016 Mina Patel Sooch
President & CEO; Director
1,212   8,132
08/10/2016 Daniela Carmen Oniciu
Vice President
245   1,643
08/10/2016 Andrew H. Sassine
Director
8,212   55,102
08/10/2016 P. Kent Hawryluk
Director
816   5,475
08/10/2016 Kenneth W Kousky
Director
10,439   70,045

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
0 Purchases
0 Sales
0
0
Link to MarketWatch's Slice.